Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2007-02-05
2008-08-19
Saoud, Christine J (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C514S002600, C514S012200, C536S023500, C435S069100
Reexamination Certificate
active
07414110
ABSTRACT:
Isolated DNA encoding each of human calcium channel α1-, α2-, β- and γ-subunits, including subunits that arise as splice variants of primary transcripts, is provided. Cells and vectors containing the DNA and methods for identifying compounds that modulate the activity of human calcium channels are also provided.
REFERENCES:
patent: 4788135 (1988-11-01), Davis et al.
patent: 4912202 (1990-03-01), Campbell et al.
patent: 4954436 (1990-09-01), Froehner et al.
patent: 5024939 (1991-06-01), Gorman et al.
patent: 5051403 (1991-09-01), Miljanich et al.
patent: 5189020 (1993-02-01), Miljanich et al.
patent: 5264371 (1993-11-01), Miljanich et al.
patent: 5386025 (1995-01-01), Jay et al.
patent: 5401629 (1995-03-01), Harpold et al.
patent: 5407820 (1995-04-01), Ellis et al.
patent: 5424218 (1995-06-01), Miljanich et al.
patent: 2085502 (1993-02-01), None
patent: 0507170 (1992-03-01), None
patent: 0556651 (1993-04-01), None
patent: 8907608 (1989-08-01), None
patent: 8909834 (1989-10-01), None
patent: 9113077 (1991-09-01), None
patent: 9202639 (1992-02-01), None
patent: 9308469 (1993-04-01), None
patent: 9402511 (1994-02-01), None
patent: 9504144 (1995-02-01), None
Lu et al. (2004). Arrhythmia in isolated prenatal hearts after ablation of the Cav2.3 (α1E) subunit of voltage-gated Ca2+ channels. Cellular Physiology and Biochemistry. 14:11-22.
Weiergräber et al. (2005). Ablation of Cav2.3/E-type voltage-gated calcium channel results in cardiac arrhythmia and altered autonomic control within the murine cardiovascular system. Basic Research in Cardiology. 100:1-13.
Jing et al. (2005). Cav2.3 calcium channels control second-phase insulin release. The Journal of Clinical Investigation. 115(1):146-154.
Miljanich and Ramachandran, “Antagonists of neuronal calcium channels: structure, function, and therapeutic implication,”Ann. Rev. Pharm. and Toxicol. 35:707-734 (1995).
Adams, et al., “Intramembrane charge movement restored in dysgenic skeletal muscle by injection of dihydropyridine receptor cDNAs,”Nature, 346:569-572 (1990).
Ahlijanian, et al., “Subunit structure and localization of dihydropyridine-sensitive calcium channels in mammalian brain, spinal cord, and retina,”Neuron, 4:819-832 (1990).
Ahlijanian, et al., “Phosphorylation of an α1-like subunit of anw-conotoxin-sensitive brain calcium channel by cAMP-dependent protein kinase and protein kinase C,”J.Biol.Chem., 266:20192 (1991).
Artalejo, et al., “w-Conotoxin GVIA blocks a Ca2+current in bovine chromaffin cells that is not of the ‘classic’ N type,”Neuron, 8:85-95 (1992).
Barhanin, et al., “The calcium channel antagonists receptor from rabbit skeletal muscle: reconstitution after purification and subunit characterization,”Eur.J.Biochem., 164:525-531 (1987).
Bean, et al., “Classes of calcium channels in vertebrate cells,”Annu.Rev. Physiol., 51:367-384 (1989).
Biel, et al., “Primary structure and functional expression of a high voltage activiated calcium channel from rabbit lung,”FEBS Letters, 269(2):409-412 (1990).
Blount, et al., “Assembly intermediates of the mouse muscle nicotinic Acetylcholine receptor in stably transfected fibroblasts,”J.Cell.Biol., 111:2601 (1990).
Borsotto, et al., “The 1,4-dihydropyridine receptor associated with the skeletal muscle voltage-dependent Ca2+channel,”J.Biol.Chem., 260(26):14255-14263 (1985).
Bosse, et al., “The cDNA and deduced amino acid sequence of the γ subunit of the L-type calcium channel from rabbit skeletal muscle,”FEBS, 267(1):153-156 (1990).
Breitbart, et al., “Alternative Splicing: A Ubiquitous Mechanism for the Generation of Multiple Protein Isoforms From Single Genes,”Ann. Rev. Biochem. 56:467-495 (1987).
Brust, et al., “Human Neuronal Voltage-Dependent Calcium Channels: Studies on Subunit Structure and Role in Channel Assembly,”Neuropharmacology32(11):1089-1102 (1993).
Burns, et al., “Calcium channel activity of purified human synexin and structure of the human synexin gene,”Proc.Natl.Acad.Sci., 86:3798-3802 (1989).
Campbell, et al., “The biochemistry and molecular biology of the dihydropyridine-sensitive calcium channel,”TINS, 11(10):425-430 (1988).
Campbell, et al., “32,000-Dalton subunit of the 1,4-dihydropyridine receptor,”Ann.N.Y.Acad.Sci., 560:251-257 (1989).
Carbone, et al., “Ca currents in human neuroblastoma IMR32 cells: kinetics, permeability and pharmacology,”Pfluegers Arch. 416:170-179 (1990) (best available copy submitted).
Catterall, et al., “Molecular properties of dihydropyridine-sensitive calcium channels in skeletal muscle,”J.Biol.Chem., 263(8):3535-3538 (1988).
Claudio, T., “Stable expression of transfectedTorpedoacetylcholine receptor α subunits in mouse fibroblast L cells,”Proc.Natl.Acad.Sci., 84:5967-5971 (1987).
Claudio, et al., “Genetic reconstitution of functional acetylcholine receptor channels in mouse fibroblasts,”Science, 238:1688-1694 (1987).
Cohen, et al., “Distribution of Ca2+channels on frog motor nerve terminals revealed by fluorescentw-conotoxin,”J. of Neuroscience, 11(4):1032-1039 (1991).
Collin, et al., “Cloning, chromosomal Location and Functional Expression of the Human Voltage-dependent Calcium Channel β3 Subunit,”Eur. J. Biochem. 220:257-262 (1994).
Cooper, et al., “Purification and characterization of the dihydropyridine-sensitive voltage-dependent calcium channel from cardiac tissue,”J.Biol.Chem., 262(2):509-512 (1987).
Cruz et al., “Characterization of ω-Conotoxin Target. Evidence for Tissue-Specific Heterogeneity ion Calcium Channel Types,”Biochem. J. 26:820 (1987).
Curran and Morgan, “Barium modulesc-fosexpression and post-translational modification,”Proc.Natl.Acad.Sci., 83:3521-8524 (1986).
Curtis, et al., “Reconstitution of the voltage-sensitive calcium channel purified from skeletal muscle transverse tubules,”Biochemistry, 25:3077-3083 (1986).
Curtis, et al., “Purification to the calcium antagonist receptor of the voltage-sensitive calcium channel from skeletal muscle transverse tubules,”Biochemistry, 23(10):2113-2118 (1984).
Dascal, et al., “Expression of modulation of voltage-gated calcium channels after RNA injection inXenopus oocytes,”Science, 231:1147-1150 (1986).
Dascal, N., “The use ofXenopus oocytesfor the study of ion channels,”CRC Critical Rev.Biochem., 22(4):317-387 (1987).
DeJongh, et al., “Subunits of purified calcium channels,”J.Biol.Chem., 265(25):14738-14741 (1990).
Dubel, et al., “Molecular cloning of the α-1 subunit of an ω-conotoxin-sensitive calcium channel,”Proc.Natl.Acad.Sci. 89:5058-5062 (1992).
Elinor, et al., “Functional expression of a rapidly inactivating neuronal calcium channel,”Nature363:455-458 (1993).
Ellis, et al., “Sequence and Expression of mRNAs Encoding the α1and α2Subunits of a DHP-Sensitive Calcium Channel,”Science, 241:1661-1664. (1988).
Feramisco, et al., “Optical spatial requirements for the location of basic residues in peptide substrates for the cyclic AMP-dependent protein kinase,”J.Biol.Chem., 255(9):4240-4245 (1980).
Fisch, et al., “c-fossequences necessary for basal expression and induction by epidermal growth factor, 12-0-tetradecanoyl phorbol-13-acetate, and the calcium inophore,”Mol.Cell.Biol., 7(10):3490-3502 (1987).
Froehner, “New insights into the molecular structure of the dihydropyridine-sensitive calcium channel,”TINS, 11(3):90-92 (1988).
Gustin, et al., “Ion channels in yeast,”Science, 233:1195-1197 (1986).
Hamill, et al., “Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches,”Pfluger Archiv.European Jou
Brenner Robert
Ellis Steven B.
Feldman Daniel H.
Gillespie Alison
Harpold Michael M.
Kohli Vineet
Krovatin William
Lockard Jon M
Merck & Co. , Inc.
Saoud Christine J
LandOfFree
Human calcium channel compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human calcium channel compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human calcium channel compositions and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4004119